[1] Mhyre T R, Boyd J T, Hamill R W, et al. Parkinson's disease[J]. Sub cell Biochem, 2012,65:389-455. [2] Blesa J, Przedborski S. Parkinson's disease: animal models and dopaminergic cell vulnerability[J]. Front Neuroanat, 2014,8:155. [3] Hipkiss A R. Aging risk factors and Parkinson's disease: contrasting roles of common dietary constituents[J]. Neurobiol Aging, 2014,35(6):1469-1472. [4] Naoi M, Maruyama W, Dostert P, et al. Dopamine-derived endogenous 1(R),2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, N-methyl-(R)-salsolinol, induced parkinsonism in rat: biochemical, pathological and behavioral studies[J]. Brain Res, 1996,709(2):285-295. [5] Morikawa N, Naoi M, Maruyama W, et al. Effects of various tetrahydroisoquinoline derivatives on mitochondrial respiration and the electron transfer complexes[J]. J Neural Transm, 1998,105(6-7):677-688. [6] Arshad A, Chen X, Cong Z, et al. TRPC1 protects dopaminergic SH-SY5Y cells from MPP+, salsolinol, and N-methyl-(R)-salsolinol-induced cytotoxicity[J]. Acta Biochim Biophysi Sin, 2014,46(1):22-30. [7] 万红贵,郭一丹,蔡恒,等.S-腺苷甲硫氨酸研究进展及市场应用分析[J].现代生物医学进展,2008,8(10):1951-1955. [8] Obeid R, Schadt A, Dillmann U, et al. Methylation status and neurodegenerative markers in Parkinson disease[J]. Clin Chem, 2009,55(10):1852-1860. [9] 王苏华,赵杨静,曾萍,等.S-腺苷蛋氨酸的神经保护作用的研究进展[J].毒理学杂志,2012,26(5):381-384. [10] Nagatsu T. Isoquinoline neurotoxins in the brain and Parkinson's disease[J]. Neurosci Res, 1997,29(2):99-111. [11] Wanpen S, Govitrapong P, Shavali S, et al. Salsolinol, a dopamine-derived tetrahydroisoquinoline, induces cell death by causing oxidative stress in dopaminergic SH-SY5Y cells, and the said effect is attenuated by metallothionein[J]. Brain Res, 2004,1005(1-2):67-76. [12] Wanpen S, Kooncumchoo P, Shavali S, et al. Salsolinol, an endogenous neurotoxin, activates JNK and NF-kappaB signaling pathways in human neuroblastoma cells[J]. Neurochemi Res, 2007,32(3):443-450. [13] Naoi M, Maruyama W, Nagy G M. Dopamine-derived salsolinol derivatives as endogenous monoamine oxidase inhibitors: occurrence, metabolism and function in human brains[J]. Neurotoxicology, 2004,25(1-2):193-204. [14] Maruyama W, Dostert P, Matsubara K, et al. N-methyl(R) salsolinol produces hydroxyl radicals: involvement to neurotoxicity[J]. Free Radic Biol Med, 1995,19(1):67-75. [15] Naoi M, Maruyama W, Akao Y, et al. Apoptosis induced by an endogenous neurotoxin, N-methyl(R) salsolinol, in dopamine neurons[J]. Toxicology, 2000,153(1-3):123-141. [16] Su Y, Duan J, Ying Z, et al. Increased vulnerability of parkin knock down PC12 cells to hydrogen peroxide toxicity: the role of salsolinol and NM-salsolinol[J]. Neuroscience, 2013,233:72-85. [17] Zhang Y, Ma H, Xie B, et al. Alpha-synuclein overexpression induced mitochondrial damage by the generation of endogenous neurotoxins in PC12 cells[J]. Neurosci Lett, 2013,547:65-69. [18] Maruyama W, Nakahara D, Ota M, et al. N-methylation of dopamine-derived 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, (R)-salsolinol, in rat brains: in vivo microdialysis study[J]. J Neurochem, 1992,59(2):395-400. [19] Naoi M, Maruyama W, Matsubara K, et al. A neutral N-methyltransferase activity in the striatum determines the level of an endogenous MPP+-like neurotoxin, 1,2-dimethyl-6,7-dihydroxyisoquinolinium ion, in the substantia nigra of human brains[J]. Neurosci Lett, 1997,235(1-2):81-84. [20] Deng Y, Zhang Y, Duan J, et al. An overview of endogenous catechol-isoquinolines and their related enzymes: possible biomarkers for Parkinson's disease[J]. Curr Tran Geriatr Gerontol Rep, 2012,1(2):59-67. [21] 张忠霞,马晓伟,顾平,等.年龄对MPTP作用于快速老化小鼠SAMP8环氧化酶2表达的影响[J].中国医科大学学报,2013,42(8):697-701. |